HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel approach to maintaining cardiovascular stability after hemorrhagic shock: beneficial effects of adrenomedullin and its binding protein.

AbstractBACKGROUND:
Vascular responsiveness to adrenomedullin (AM), a recently discovered vasodilator peptide, is depressed after hemorrhage and resuscitation. Downregulation of AM binding protein-1 (ie, AMBP-1) appears to be responsible for this hyporesponsiveness. Therefore, we hypothesize that administration of AM/AMBP-1 improves cardiovascular responses after hemorrhagic shock and resuscitation.
METHODS:
Male rats were bled to and maintained at a mean blood pressure of 40 mm Hg for 90 minutes. The animals were then resuscitated with 4 times the volume of shed blood with Ringer's lactate over 60 minutes. At 15 minutes after the beginning of resuscitation in hemorrhaged animals, AM alone, AMBP-1 alone, AM in combination with AMBP-1, or vehicle (phosphate-buffered saline solution) was administered intravenously over 45 minutes. At 4-hour postresuscitation, in vivo left ventricular contractility parameters, maximal rates of ventricular pressure increase (+dP/dt max ) and decrease (-dP/dt max ), were determined. Cardiac output and organ blood flow were measured with the use of radioactive microspheres. In an additional group of animals, cardiac tumor necrosis factor-alpha (TNF-alpha) levels were measured by an enzyme-linked immunosorbent assay.
RESULTS:
Four hours after resuscitation, +dP/dt max , -dP/dt max , cardiac output, and organ blood flow in the liver, small intestine, and kidneys were decreased while treatment with AM/AMBP-1 increased these parameters ( P < .05). Moreover, cardiac TNF-alpha levels were elevated at 4 hours after hemorrhage and resuscitation, while AM/AMBP-1 treatment reduced them to sham levels ( P < .05).
CONCLUSIONS:
Administration of AM/AMBP-1 appears to be a useful approach for restoring and maintaining cardiovascular stability after severe hemorrhagic shock and crystalloid resuscitation.
AuthorsRongqian Wu, Weifeng Dong, Mian Zhou, Xiaoxuan Cui, H Hank Simms, Ping Wang
JournalSurgery (Surgery) Vol. 137 Issue 2 Pg. 200-8 (Feb 2005) ISSN: 0039-6060 [Print] United States
PMID15674202 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • CFH protein, human
  • Peptides
  • Tumor Necrosis Factor-alpha
  • adrenomedullin-binding protein 1, human
  • Adrenomedullin
  • Complement Factor H
Topics
  • Adrenomedullin
  • Animals
  • Blood Pressure (drug effects)
  • Cardiac Output (drug effects)
  • Complement Factor H (therapeutic use)
  • Heart Rate (drug effects)
  • Humans
  • Male
  • Myocardial Contraction (drug effects)
  • Peptides (therapeutic use)
  • Rats
  • Rats, Sprague-Dawley
  • Shock, Hemorrhagic (drug therapy, physiopathology)
  • Tumor Necrosis Factor-alpha (metabolism)
  • Ventricular Function, Left (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: